Literature DB >> 16732730

Radical scavenging activity of ribonuclease inhibitor from cow placenta.

Shuo Wang1, Haiping Li.   

Abstract

Cow placenta ribonuclease inhibitor (CPRI) has been purified 5062-fold by affinity chromatography, the product being homogeneous by sodium dodecyl sulfate-gel electrophoresis. The chemiluminescence technique was used to determine the radical scavenging activities of CPRI toward different reactive oxygen species (ROS) including superoxide anion (O2-*), hydroxyl radical (OH*), lipid-derived radicals (R*), and singlet oxygen (1O2). CPRI could effectively scavenge O2-*, OH*, R*, and 1O2 at EC50 of 0.12, 0.008, 0.009, and 0.006 mg/ml, respectively. In addition, the radical scavenging activities of CPRI were higher than those of tea polyphenols, indicating that CPRI is a powerful antioxidant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732730     DOI: 10.1134/s0006297906050087

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  4 in total

1.  Intraspecies regulation of ribonucleolytic activity.

Authors:  R Jeremy Johnson; Luke D Lavis; Ronald T Raines
Journal:  Biochemistry       Date:  2007-10-23       Impact factor: 3.162

2.  Functional evolution of ribonuclease inhibitor: insights from birds and reptiles.

Authors:  Jo E Lomax; Christopher M Bianchetti; Aram Chang; George N Phillips; Brian G Fox; Ronald T Raines
Journal:  J Mol Biol       Date:  2014-06-15       Impact factor: 5.469

3.  Protective Effects of Kuding Tea (Ilex kudingcha C. J. Tseng) Polyphenols on UVB-Induced Skin Aging in SKH1 Hairless Mice.

Authors:  Ruokun Yi; Jing Zhang; Peng Sun; Yu Qian; Xin Zhao
Journal:  Molecules       Date:  2019-03-13       Impact factor: 4.411

4.  Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.

Authors:  Xiang Zhuang; Mengxin Lv; Zhenyu Zhong; Luyu Zhang; Rong Jiang; Junxia Chen
Journal:  J Exp Clin Cancer Res       Date:  2016-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.